מונטהלוקאסט טבע ® 5 מ"ג

Pajjiż: Iżrael

Lingwa: Ebrajk

Sors: Ministry of Health

Ingredjent attiv:

MONTELUKAST AS SODIUM 5 MG

Disponibbli minn:

SALOMON,LEVIN & ELSTEIN LTD

Kodiċi ATC:

R03DC03

Għamla farmaċewtika:

CHEWABLE TABLETS

Rotta amministrattiva:

PER OS

Manifatturat minn:

TEVA OPERATIONS POLAND SP.ZO.O

Grupp terapewtiku:

MONTELUKAST

Indikazzjonijiet terapewtiċi:

Montelukast Teva is indicated in pediatric patients 6 to 14 years of age for the prophylaxis and chronic treatment of asthma including prevention of daytime and nighttime symptoms the treatment of aspirin-sensitive asthmatic patients and the prevention of exercise-induced bronchoconstriction.Montelukast Teva is effective alone or in combination with other agents used in the maintenance treatment of chronic asthma. Montelukast Teva and inhaled corticosteroids may be used concomitantly with additive effects to control asthma or to reduce the inhaled corticosteroid dose while maintaining clinical stability. Montelukast Teva is indicated for the relief of symptoms of seasonal allergic rhinitis in pediatric patients 6 to 14 years of age and older.

Data ta 'l-awtorizzazzjoni:

2011-05-01